Citadel Advisors’s Jaguar Health JAGX Stock Holding History

Citadel Advisors’s Portfolio JAGX Stock Details JAGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1	Closed	-$29.3K	–	15032
2023 Q4	$29.3K	Buy	+1	New	+$103K	﹤0.01%	12286
2023 Q3	–	Hold	0	–	-$8.01K	–	14703
2023 Q2	–	Hold	0	–	–	–	13344
2023 Q1	–	Hold	0	–	-$87.1K	–	15101
2022 Q4	–	Hold	0	–	–	–	11405
2022 Q2	–	Hold	0	–	–	–	13494
2022 Q1	–	Hold	0	–	–	–	11822
2021 Q4	–	Hold	0	–	–	–	13027
2021 Q3	–	Hold	0	–	–	–	12261
2021 Q2	–	Hold	0	–	–	–	13546
2021 Q1	–	Hold	0	–	–	–	12013
2020 Q4	–	Hold	0	–	-$111K	–	11223
2020 Q3	–	Hold	0	–	–	–	9215
2020 Q2	–	Hold	0	–	–	–	9612
2019 Q1	–	Hold	0	–	-$3K	–	9587
2018 Q4	–	Hold	0	–	–	–	8996
2018 Q3	–	Hold	0	–	–	–	8864
2018 Q2	–	Hold	0	–	-$8K	–	9062
2018 Q1	–	Hold	0	–	–	–	8186
2017 Q4	–	Hold	0	–	–	–	7724

Other funds holding JAGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Csenge Advisory Group Clearwater, Florida $2.47B AUM 24.93% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Citadel Advisors's JAGX Position: Q1 2024 in Review

Citadel Advisors sold out of Jaguar Health (JAGX) in Q1 2024, closing a stake of 1 share — an estimated $29.3K sold.

Citadel Advisors first reported a position in JAGX in Q4 2023 and held it in 1 quarter. The position peaked at $29.3K in Q4 2023. 6 funds tracked by Wall St. Rank hold JAGX as of Q1 2024.

Citadel Advisors reported no remaining Jaguar Health position as of Q1 2024 after selling out during the quarter.
Citadel Advisors sold 1 Jaguar Health share in Q1 2024, an estimated $29.3K.
Citadel Advisors first reported a position in Jaguar Health in Q4 2023 and held it in 1 quarter.
Citadel Advisors's Jaguar Health position peaked at $29.3K in Q4 2023.
6 funds tracked by Wall St. Rank held Jaguar Health as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.